drugset / Trial / NCT01416480

Clinical Trial to Evaluate the Safety and Efficacy of "Theobromine Capsule" as an Antitussive in Acute Cougher

NCT01416480

Phase 3 Completed 332 enrolled Ahn-Gook Pharmaceuticals Co.,Ltd
RandomizedParallel-groupQuadruple-blindTreatment

Summary

The aim of this clinical trial is to evaluate the antitussive effect of "Theobromine capsule 300mg" in patients with acute bronchitis.

Timeline

Start
2010-05
Primary completion
2011-02
Completion
2011-05

Drugs

EvaluationDrugModalityDoseRoute
Comparator Levodropropizine Small molecule 10 mg
Subject Theobromine Small molecule 300 mg

Indications